Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin + Chemotherapy for Metastatic TNBC
NCT04722978Phase 3Recruiting
- Sponsor
- Sun Yat-sen University Cancer Center
- Start
- Apr 2021
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin in triple-negative breast cancer (TNBC), sponsored by Sun Yat-sen University Cancer Center. Started Apr 2021; status: recruiting.
02
Drugs
moxifloxacin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT04722978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04722978.